Hiroyuki Yamaguchi

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Kazuhiko Nakagawa, Edward B. Garon, Takashi Seto et al. · The Lancet Oncology · 2019 · 613 citations · Full text

Medicine, Oncology, Pharmacology +12

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang et al. · Nature Communications · 2019 · 363 citations · Full text

Medicine, Oncology, Pharmacology +17

Genomic characterization of primary central nervous system lymphoma

Kazutaka Fukumura, Masahito Kawazu, Shinya Kojima et al. · Acta Neuropathologica · 2016 · 185 citations

Medicine, Genetics, Molecular Genetics +14

Role of disseminated intravascular coagulation in severe sepsis

Satoshi Gando, Atsushi Shiraishi, Kazuma Yamakawa et al. · Thrombosis Research · 2019 · 137 citations

Veterinary Medicine, Hematology, Infectious Diseases +13

Transforming mutations of RAC guanosine triphosphatases in human cancers

Masahito Kawazu, Toshihide Ueno, Kenji Kontani et al. · Proceedings of the National Academy of Sciences · 2013 · 125 citations · Full text

Medicine, Cancer Biology, Molecular Biology +17